Exploration of In-vitro Antidiabetic Activity of ZnO NPs and Ag NPs Synthesized using Methanolic Extracts of Alpinia mutica and Tradescantia spathaeca Leaves

Diabetes might be cured with the use of medicinal herbs and environmentally friendly production of metallic nanoparticles (Ag NPs) and ZnO NPs. The methanolic leaf extracts of Alpinia mutica and Tradescantia spathaeca were used to synthesize silver nanoparticles (Ag NPs) and zinc oxide nanoparticles (ZnO NPs), respectively, for in-vitro evaluation. Methanolic leaf extracts of A. mutica and T. spathaeca were used to create AgNPs and ZnO NPs under ambient conditions using ultrasound-assisted extraction (UAE). Their ability to block alpha- and beta-amylase confirmed the in-vitro antidiabetic efficacy of methanolic leaf extract of plant (MLEP), AgNPs, and ZnO NPs. In this study, α- amylase activity of ZnO and nanoparticles of silver produced from natural sources will be evaluated in an effort to lessen the toxicity and negative effects of the inhibitor used to treat diabetes. Antidiabetic action was especially impressive in the ZnO and silver nanoparticles produced using methanolic extracts of A. mutica and T. spathaeca. Because of their promising in-vitro antidiabetic action with alpha-amylase activity, MLEP of A. mutica and T. spathaeca, AgNPs, and ZnO NPs show promise for future medical uses.